Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Everest Medicines Limited (6HN.F)

Compare
6.65
+0.20
+(3.10%)
At close: April 4 at 8:02:48 AM GMT+2
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
125,932
125,932
12,792
54
--
Cost of Revenue
34,414
34,414
4,645
23
--
Gross Profit
91,518
91,518
8,147
31
--
Operating Expense
923,453
923,453
1,408,346
1,049,303
687,406
Operating Income
-831,935
-831,935
-1,400,199
-1,049,272
-687,406
Net Non Operating Interest Income Expense
84,608
84,608
32,887
24,065
-31,827
Pretax Income
-844,463
-844,463
-247,275
-1,008,719
-5,658,165
Tax Provision
--
--
8
--
--
Net Income Common Stockholders
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Diluted NI Available to Com Stockholders
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Basic EPS
-2.70
-2.70
-0.83
-3.44
-66.29
Diluted EPS
-2.70
-2.70
-0.83
-3.44
-66.29
Basic Average Shares
313,062.81
313,062.81
297,635
293,272.15
85,350.49
Diluted Average Shares
313,062.81
313,062.81
297,635
293,272.15
85,350.49
Total Operating Income as Reported
-932,738
-932,738
-256,800
-1,026,332
-688,457
Total Expenses
957,867
957,867
1,412,991
1,049,326
687,406
Net Income from Continuing & Discontinued Operation
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Normalized Income
-794,732
-794,732
-1,207,073
-1,002,267
-720,182
Interest Income
107,667
107,667
38,478
28,881
2,039
Interest Expense
23,059
23,059
5,591
4,816
23,820
Net Interest Income
84,608
84,608
32,887
24,065
-31,827
EBIT
-821,404
-821,404
-241,684
-1,003,903
-5,634,345
EBITDA
-744,628
-744,628
-198,912
-972,779
-5,613,950
Reconciled Cost of Revenue
34,414
34,414
4,645
23
--
Reconciled Depreciation
76,776
76,776
42,772
31,124
20,395
Net Income from Continuing Operation Net Minority Interest
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Total Unusual Items Excluding Goodwill
-49,731
-49,731
1,279,720
-6,452
-4,937,983
Total Unusual Items
-49,731
-49,731
1,279,720
-6,452
-4,937,983
Normalized EBITDA
-694,897
-694,897
-1,478,632
-966,327
-675,967
Tax Rate for Calcs
--
--
0
--
--
Tax Effect of Unusual Items
--
--
319,930
--
--
12/31/2020 - 10/13/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BOT.AX Botanix Pharmaceuticals Limited
0.4000
-5.88%
 
MSB.AX Mesoblast Limited
1.7650
-5.87%
 
MESO Mesoblast Limited
10.57
-8.88%
 
VERV Verve Therapeutics, Inc.
3.6200
-5.85%
 
NTLA Intellia Therapeutics, Inc.
6.63
-3.77%